About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

2016 May 19 AGM Chairman and CEO Addresses

May 19, 2016

Click here to read more

Post navigation

Retirement of Non-Executive Director

Appointment of Non-Executive Director

Related Posts

Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial

January 29, 2016

Quarterly Activities Report and 4C – to 31 March 2023

April 28, 2023May 20, 2023

Quarterly Activities Report and 4C

July 27, 2021July 27, 2021

Recent Posts

US & EU Patent Allowances for CBD Soft-Gel Formulation
December 3, 2025
Research report | RaaS Watchlist: Waking the Sleeping Giant
August 26, 2025
Media | Avecho featured on 9 News
June 23, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.